Health
COVID-19 vaccine study has a warning for people who take common IBD drug – SlashGear
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower…
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD.
Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own immune system, resulting in the development of antibodies that help protect the individual from an infection caused by…
-
Noosa News17 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News18 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News24 hours agoScenic Rim council cracks down on farmers hosting campers without a permit
-
General16 hours agoTruck driver charged with causing death by dangerous driving after highway crash